Global Ropivacaine Market Research Report 2020

Global Ropivacaine Market Research Report 2020

Table of Contents
1 Ropivacaine Market Overview
1.1 Product Overview and Scope of Ropivacaine
1.2 Ropivacaine Segment by Type
1.2.1 Global Ropivacaine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Lumbar Epidural Administration
1.2.3 Thoracic Epidural Administration
1.2.4 Regional Block
1.3 Ropivacaine Segment by Application
1.3.1 Ropivacaine Sales Comparison by Application: 2020 VS 2026
1.3.2 Anesthesia
1.3.3 Systemic Neuropathic Pain
1.3.4 Postherpes Pain
1.3.5 Post-Operative Pain
1.3.6 Surgical Analgesia
1.3.7 Labor Analgesia
1.3.8 Other
1.4 Global Ropivacaine Market Size Estimates and Forecasts
1.4.1 Global Ropivacaine Revenue 2015-2026
1.4.2 Global Ropivacaine Sales 2015-2026
1.4.3 Ropivacaine Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Ropivacaine Industry Impact
1.5.1 How the Covid-19 is Affecting the Ropivacaine Industry
1.5.1.1 Ropivacaine Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Ropivacaine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Ropivacaine Players to Combat Covid-19 Impact
2 Global Ropivacaine Market Competition by Manufacturers
2.1 Global Ropivacaine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Ropivacaine Revenue Share by Manufacturers (2015-2020)
2.3 Global Ropivacaine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Ropivacaine Manufacturing Sites, Area Served, Product Type
2.5 Ropivacaine Market Competitive Situation and Trends
2.5.1 Ropivacaine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Ropivacaine Players (Opinion Leaders)
3 Ropivacaine Retrospective Market Scenario by Region
3.1 Global Ropivacaine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Ropivacaine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Ropivacaine Market Facts & Figures by Country
3.3.1 North America Ropivacaine Sales by Country
3.3.2 North America Ropivacaine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ropivacaine Market Facts & Figures by Country
3.4.1 Europe Ropivacaine Sales by Country
3.4.2 Europe Ropivacaine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ropivacaine Market Facts & Figures by Region
3.5.1 Asia Pacific Ropivacaine Sales by Region
3.5.2 Asia Pacific Ropivacaine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ropivacaine Market Facts & Figures by Country
3.6.1 Latin America Ropivacaine Sales by Country
3.6.2 Latin America Ropivacaine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Ropivacaine Market Facts & Figures by Country
3.7.1 Middle East and Africa Ropivacaine Sales by Country
3.7.2 Middle East and Africa Ropivacaine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Ropivacaine Historic Market Analysis by Type
4.1 Global Ropivacaine Sales Market Share by Type (2015-2020)
4.2 Global Ropivacaine Revenue Market Share by Type (2015-2020)
4.3 Global Ropivacaine Price Market Share by Type (2015-2020)
4.4 Global Ropivacaine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Ropivacaine Historic Market Analysis by Application
5.1 Global Ropivacaine Sales Market Share by Application (2015-2020)
5.2 Global Ropivacaine Revenue Market Share by Application (2015-2020)
5.3 Global Ropivacaine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Ropivacaine Business
6.1 AstraZeneca
6.1.1 Corporation Information
6.1.2 AstraZeneca Description, Business Overview and Total Revenue
6.1.3 AstraZeneca Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AstraZeneca Products Offered
6.1.5 AstraZeneca Recent Development
6.2 Aspen Pharmacare
6.2.1 Aspen Pharmacare Corporation Information
6.2.2 Aspen Pharmacare Description, Business Overview and Total Revenue
6.2.3 Aspen Pharmacare Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Aspen Pharmacare Products Offered
6.2.5 Aspen Pharmacare Recent Development
6.3 Celgene
6.3.1 Celgene Corporation Information
6.3.2 Celgene Description, Business Overview and Total Revenue
6.3.3 Celgene Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Celgene Products Offered
6.3.5 Celgene Recent Development
6.4 Taiwan Liposome Company
6.4.1 Taiwan Liposome Company Corporation Information
6.4.2 Taiwan Liposome Company Description, Business Overview and Total Revenue
6.4.3 Taiwan Liposome Company Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Taiwan Liposome Company Products Offered
6.4.5 Taiwan Liposome Company Recent Development
6.5 Nuvo Pharmaceuticals
6.5.1 Nuvo Pharmaceuticals Corporation Information
6.5.2 Nuvo Pharmaceuticals Description, Business Overview and Total Revenue
6.5.3 Nuvo Pharmaceuticals Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Nuvo Pharmaceuticals Products Offered
6.5.5 Nuvo Pharmaceuticals Recent Development
6.6 Heron Therapeutics
6.6.1 Heron Therapeutics Corporation Information
6.6.2 Heron Therapeutics Description, Business Overview and Total Revenue
6.6.3 Heron Therapeutics Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Heron Therapeutics Products Offered
6.6.5 Heron Therapeutics Recent Development
6.7 Encore Therapeutics
6.6.1 Encore Therapeutics Corporation Information
6.6.2 Encore Therapeutics Description, Business Overview and Total Revenue
6.6.3 Encore Therapeutics Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Encore Therapeutics Products Offered
6.7.5 Encore Therapeutics Recent Development
6.8 PainReform Ltd
6.8.1 PainReform Ltd Corporation Information
6.8.2 PainReform Ltd Description, Business Overview and Total Revenue
6.8.3 PainReform Ltd Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 PainReform Ltd Products Offered
6.8.5 PainReform Ltd Recent Development
6.9 Anhui Wellman Pharmaceutical
6.9.1 Anhui Wellman Pharmaceutical Corporation Information
6.9.2 Anhui Wellman Pharmaceutical Description, Business Overview and Total Revenue
6.9.3 Anhui Wellman Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Anhui Wellman Pharmaceutical Products Offered
6.9.5 Anhui Wellman Pharmaceutical Recent Development
6.10 Yichang Renfu Pharmaceutical
6.10.1 Yichang Renfu Pharmaceutical Corporation Information
6.10.2 Yichang Renfu Pharmaceutical Description, Business Overview and Total Revenue
6.10.3 Yichang Renfu Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Yichang Renfu Pharmaceutical Products Offered
6.10.5 Yichang Renfu Pharmaceutical Recent Development
6.11 Shandong New Era Pharmaceutical
6.11.1 Shandong New Era Pharmaceutical Corporation Information
6.11.2 Shandong New Era Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.11.3 Shandong New Era Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Shandong New Era Pharmaceutical Products Offered
6.11.5 Shandong New Era Pharmaceutical Recent Development
6.12 Shanxi Pude Pharmaceutical
6.12.1 Shanxi Pude Pharmaceutical Corporation Information
6.12.2 Shanxi Pude Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.12.3 Shanxi Pude Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Shanxi Pude Pharmaceutical Products Offered
6.12.5 Shanxi Pude Pharmaceutical Recent Development
6.13 Guangdong Huarun Shunfeng Pharmaceutical
6.13.1 Guangdong Huarun Shunfeng Pharmaceutical Corporation Information
6.13.2 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.13.3 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Guangdong Huarun Shunfeng Pharmaceutical Products Offered
6.13.5 Guangdong Huarun Shunfeng Pharmaceutical Recent Development
6.14 Guangdong Jiabo Pharmaceutical
6.14.1 Guangdong Jiabo Pharmaceutical Corporation Information
6.14.2 Guangdong Jiabo Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.14.3 Guangdong Jiabo Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Guangdong Jiabo Pharmaceutical Products Offered
6.14.5 Guangdong Jiabo Pharmaceutical Recent Development
6.15 Chengdu Tiantaishan Pharmaceutical
6.15.1 Chengdu Tiantaishan Pharmaceutical Corporation Information
6.15.2 Chengdu Tiantaishan Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.15.3 Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Chengdu Tiantaishan Pharmaceutical Products Offered
6.15.5 Chengdu Tiantaishan Pharmaceutical Recent Development
6.16 Yangtze Pharmaceutical Group
6.16.1 Yangtze Pharmaceutical Group Corporation Information
6.16.2 Yangtze Pharmaceutical Group Ropivacaine Description, Business Overview and Total Revenue
6.16.3 Yangtze Pharmaceutical Group Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Yangtze Pharmaceutical Group Products Offered
6.16.5 Yangtze Pharmaceutical Group Recent Development
6.17 Jiangsu Hengrui Pharmaceutical
6.17.1 Jiangsu Hengrui Pharmaceutical Corporation Information
6.17.2 Jiangsu Hengrui Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.17.3 Jiangsu Hengrui Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Jiangsu Hengrui Pharmaceutical Products Offered
6.17.5 Jiangsu Hengrui Pharmaceutical Recent Development
6.18 Jiangsu Enhua Pharmaceutical
6.18.1 Jiangsu Enhua Pharmaceutical Corporation Information
6.18.2 Jiangsu Enhua Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.18.3 Jiangsu Enhua Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Jiangsu Enhua Pharmaceutical Products Offered
6.18.5 Jiangsu Enhua Pharmaceutical Recent Development
6.19 Hebei Yipin Pharmaceutical
6.19.1 Hebei Yipin Pharmaceutical Corporation Information
6.19.2 Hebei Yipin Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.19.3 Hebei Yipin Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Hebei Yipin Pharmaceutical Products Offered
6.19.5 Hebei Yipin Pharmaceutical Recent Development
6.20 Zhejiang Xianju Pharmaceutical
6.20.1 Zhejiang Xianju Pharmaceutical Corporation Information
6.20.2 Zhejiang Xianju Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.20.3 Zhejiang Xianju Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Zhejiang Xianju Pharmaceutical Products Offered
6.20.5 Zhejiang Xianju Pharmaceutical Recent Development
6.21 Hainan Sida Pharmaceutical
6.21.1 Hainan Sida Pharmaceutical Corporation Information
6.21.2 Hainan Sida Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.21.3 Hainan Sida Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.21.4 Hainan Sida Pharmaceutical Products Offered
6.21.5 Hainan Sida Pharmaceutical Recent Development
6.22 Xi'an Hanfeng Pharmaceutical
6.22.1 Xi'an Hanfeng Pharmaceutical Corporation Information
6.22.2 Xi'an Hanfeng Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.22.3 Xi'an Hanfeng Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.22.4 Xi'an Hanfeng Pharmaceutical Products Offered
6.22.5 Xi'an Hanfeng Pharmaceutical Recent Development
6.23 Chenxin Pharmaceutical
6.23.1 Chenxin Pharmaceutical Corporation Information
6.23.2 Chenxin Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.23.3 Chenxin Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.23.4 Chenxin Pharmaceutical Products Offered
6.23.5 Chenxin Pharmaceutical Recent Development
6.24 Shaanxi Bosen Biopharmaceutical
6.24.1 Shaanxi Bosen Biopharmaceutical Corporation Information
6.24.2 Shaanxi Bosen Biopharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.24.3 Shaanxi Bosen Biopharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.24.4 Shaanxi Bosen Biopharmaceutical Products Offered
6.24.5 Shaanxi Bosen Biopharmaceutical Recent Development
6.25 Qilu Pharmaceutical
6.25.1 Qilu Pharmaceutical Corporation Information
6.25.2 Qilu Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.25.3 Qilu Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.25.4 Qilu Pharmaceutical Products Offered
6.25.5 Qilu Pharmaceutical Recent Development
6.26 Shenyang Sansheng Pharmaceutical
6.26.1 Shenyang Sansheng Pharmaceutical Corporation Information
6.26.2 Shenyang Sansheng Pharmaceutical Ropivacaine Description, Business Overview and Total Revenue
6.26.3 Shenyang Sansheng Pharmaceutical Ropivacaine Sales, Revenue and Gross Margin (2015-2020)
6.26.4 Shenyang Sansheng Pharmaceutical Products Offered
6.26.5 Shenyang Sansheng Pharmaceutical Recent Development
7 Ropivacaine Manufacturing Cost Analysis
7.1 Ropivacaine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ropivacaine
7.4 Ropivacaine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ropivacaine Distributors List
8.3 Ropivacaine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Ropivacaine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ropivacaine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Ropivacaine by Type (2021-2026)
10.2 Ropivacaine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ropivacaine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Ropivacaine by Application (2021-2026)
10.3 Ropivacaine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ropivacaine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Ropivacaine by Region (2021-2026)
10.4 North America Ropivacaine Estimates and Projections (2021-2026)
10.5 Europe Ropivacaine Estimates and Projections (2021-2026)
10.6 Asia Pacific Ropivacaine Estimates and Projections (2021-2026)
10.7 Latin America Ropivacaine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Ropivacaine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Ropivacaine Sales (K Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Ropivacaine Sales (K Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Ropivacaine Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Ropivacaine Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Ropivacaine Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Ropivacaine Players to Combat Covid-19 Impact
Table 9. Global Key Ropivacaine Manufacturers Covered in This Study
Table 10. Global Ropivacaine Sales (K Doses) by Manufacturers (2015-2020)
Table 11. Global Ropivacaine Sales Share by Manufacturers (2015-2020)
Table 12. Global Ropivacaine Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Ropivacaine Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Ropivacaine Average Price (US$/Dose) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Ropivacaine Sales Sites and Area Served
Table 16. Manufacturers Ropivacaine Product Types
Table 17. Global Ropivacaine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Ropivacaine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ropivacaine as of 2019)
Table 19. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Ropivacaine Players
Table 21. Global Ropivacaine Sales (K Doses) by Region (2015-2020)
Table 22. Global Ropivacaine Sales Market Share by Region (2015-2020)
Table 23. Global Ropivacaine Revenue (Million US$) by Region (2015-2020)
Table 24. Global Ropivacaine Revenue Market Share by Region (2015-2020)
Table 25. North America Ropivacaine Sales by Country (2015-2020) (K Doses)
Table 26. North America Ropivacaine Sales Market Share by Country (2015-2020)
Table 27. North America Ropivacaine Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Ropivacaine Revenue Market Share by Country (2015-2020)
Table 29. Europe Ropivacaine Sales by Country (2015-2020) (K Doses)
Table 30. Europe Ropivacaine Sales Market Share by Country (2015-2020)
Table 31. Europe Ropivacaine Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Ropivacaine Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Ropivacaine Sales by Region (2015-2020) (K Doses)
Table 34. Asia Pacific Ropivacaine Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Ropivacaine Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Ropivacaine Revenue Market Share by Region (2015-2020)
Table 37. Latin America Ropivacaine Sales by Country (2015-2020) (K Doses)
Table 38. Latin America Ropivacaine Sales Market Share by Country (2015-2020)
Table 39. Latin America Ropivacaine Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Ropivacaine Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Ropivacaine Sales by Country (2015-2020) (K Doses)
Table 42. Middle East and Africa Ropivacaine Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Ropivacaine Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Ropivacaine Revenue Market Share by Country (2015-2020)
Table 45. Global Ropivacaine Sales (K Doses) by Type (2015-2020)
Table 46. Global Ropivacaine Sales Share by Type (2015-2020)
Table 47. Global Ropivacaine Revenue (Million US$) by Type (2015-2020)
Table 48. Global Ropivacaine Revenue Share by Type (2015-2020)
Table 49. Global Ropivacaine Price (US$/Dose) by Type (2015-2020)
Table 50. Global Ropivacaine Sales (K Doses) by Application (2015-2020)
Table 51. Global Ropivacaine Sales Market Share by Application (2015-2020)
Table 52. Global Ropivacaine Sales Growth Rate by Application (2015-2020)
Table 53. AstraZeneca Ropivacaine Corporation Information
Table 54. AstraZeneca Description and Business Overview
Table 55. AstraZeneca Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 56. AstraZeneca Main Product
Table 57. AstraZeneca Recent Development
Table 58. Aspen Pharmacare Ropivacaine Corporation Information
Table 59. Aspen Pharmacare Corporation Information
Table 60. Aspen Pharmacare Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 61. Aspen Pharmacare Main Product
Table 62. Aspen Pharmacare Recent Development
Table 63. Celgene Ropivacaine Corporation Information
Table 64. Celgene Corporation Information
Table 65. Celgene Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 66. Celgene Main Product
Table 67. Celgene Recent Development
Table 68. Taiwan Liposome Company Ropivacaine Corporation Information
Table 69. Taiwan Liposome Company Corporation Information
Table 70. Taiwan Liposome Company Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 71. Taiwan Liposome Company Main Product
Table 72. Taiwan Liposome Company Recent Development
Table 73. Nuvo Pharmaceuticals Ropivacaine Corporation Information
Table 74. Nuvo Pharmaceuticals Corporation Information
Table 75. Nuvo Pharmaceuticals Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 76. Nuvo Pharmaceuticals Main Product
Table 77. Nuvo Pharmaceuticals Recent Development
Table 78. Heron Therapeutics Ropivacaine Corporation Information
Table 79. Heron Therapeutics Corporation Information
Table 80. Heron Therapeutics Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 81. Heron Therapeutics Main Product
Table 82. Heron Therapeutics Recent Development
Table 83. Encore Therapeutics Ropivacaine Corporation Information
Table 84. Encore Therapeutics Corporation Information
Table 85. Encore Therapeutics Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 86. Encore Therapeutics Main Product
Table 87. Encore Therapeutics Recent Development
Table 88. PainReform Ltd Ropivacaine Corporation Information
Table 89. PainReform Ltd Corporation Information
Table 90. PainReform Ltd Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 91. PainReform Ltd Main Product
Table 92. PainReform Ltd Recent Development
Table 93. Anhui Wellman Pharmaceutical Ropivacaine Corporation Information
Table 94. Anhui Wellman Pharmaceutical Corporation Information
Table 95. Anhui Wellman Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 96. Anhui Wellman Pharmaceutical Main Product
Table 97. Anhui Wellman Pharmaceutical Recent Development
Table 98. Yichang Renfu Pharmaceutical Ropivacaine Corporation Information
Table 99. Yichang Renfu Pharmaceutical Corporation Information
Table 100. Yichang Renfu Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 101. Yichang Renfu Pharmaceutical Main Product
Table 102. Yichang Renfu Pharmaceutical Recent Development
Table 103. Shandong New Era Pharmaceutical Ropivacaine Corporation Information
Table 104. Shandong New Era Pharmaceutical Corporation Information
Table 105. Shandong New Era Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 106. Shandong New Era Pharmaceutical Main Product
Table 107. Shandong New Era Pharmaceutical Recent Development
Table 108. Shanxi Pude Pharmaceutical Ropivacaine Corporation Information
Table 109. Shanxi Pude Pharmaceutical Corporation Information
Table 110. Shanxi Pude Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 111. Shanxi Pude Pharmaceutical Main Product
Table 112. Shanxi Pude Pharmaceutical Recent Development
Table 113. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Corporation Information
Table 114. Guangdong Huarun Shunfeng Pharmaceutical Corporation Information
Table 115. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 116. Guangdong Huarun Shunfeng Pharmaceutical Main Product
Table 117. Guangdong Huarun Shunfeng Pharmaceutical Recent Development
Table 118. Guangdong Jiabo Pharmaceutical Ropivacaine Corporation Information
Table 119. Guangdong Jiabo Pharmaceutical Corporation Information
Table 120. Guangdong Jiabo Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 121. Guangdong Jiabo Pharmaceutical Main Product
Table 122. Guangdong Jiabo Pharmaceutical Recent Development
Table 123. Chengdu Tiantaishan Pharmaceutical Ropivacaine Corporation Information
Table 124. Chengdu Tiantaishan Pharmaceutical Corporation Information
Table 125. Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 126. Chengdu Tiantaishan Pharmaceutical Main Product
Table 127. Chengdu Tiantaishan Pharmaceutical Recent Development
Table 128. Yangtze Pharmaceutical Group Ropivacaine Corporation Information
Table 129. Yangtze Pharmaceutical Group Corporation Information
Table 130. Yangtze Pharmaceutical Group Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 131. Yangtze Pharmaceutical Group Main Product
Table 132. Yangtze Pharmaceutical Group Recent Development
Table 133. Jiangsu Hengrui Pharmaceutical Ropivacaine Corporation Information
Table 134. Jiangsu Hengrui Pharmaceutical Corporation Information
Table 135. Jiangsu Hengrui Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 136. Jiangsu Hengrui Pharmaceutical Main Product
Table 137. Jiangsu Hengrui Pharmaceutical Recent Development
Table 138. Jiangsu Enhua Pharmaceutical Ropivacaine Corporation Information
Table 139. Jiangsu Enhua Pharmaceutical Corporation Information
Table 140. Jiangsu Enhua Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 141. Jiangsu Enhua Pharmaceutical Main Product
Table 142. Jiangsu Enhua Pharmaceutical Recent Development
Table 143. Hebei Yipin Pharmaceutical Ropivacaine Corporation Information
Table 144. Hebei Yipin Pharmaceutical Corporation Information
Table 145. Hebei Yipin Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 146. Hebei Yipin Pharmaceutical Main Product
Table 147. Hebei Yipin Pharmaceutical Recent Development
Table 148. Zhejiang Xianju Pharmaceutical Ropivacaine Corporation Information
Table 149. Zhejiang Xianju Pharmaceutical Corporation Information
Table 150. Zhejiang Xianju Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 151. Zhejiang Xianju Pharmaceutical Main Product
Table 152. Zhejiang Xianju Pharmaceutical Recent Development
Table 153. Hainan Sida Pharmaceutical Ropivacaine Corporation Information
Table 154. Hainan Sida Pharmaceutical Corporation Information
Table 155. Hainan Sida Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 156. Hainan Sida Pharmaceutical Main Product
Table 157. Hainan Sida Pharmaceutical Recent Development
Table 158. Xi'an Hanfeng Pharmaceutical Ropivacaine Corporation Information
Table 159. Xi'an Hanfeng Pharmaceutical Corporation Information
Table 160. Xi'an Hanfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 161. Xi'an Hanfeng Pharmaceutical Main Product
Table 162. Xi'an Hanfeng Pharmaceutical Recent Development
Table 163. Chenxin Pharmaceutical Ropivacaine Corporation Information
Table 164. Chenxin Pharmaceutical Corporation Information
Table 165. Chenxin Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 166. Chenxin Pharmaceutical Main Product
Table 167. Chenxin Pharmaceutical Recent Development
Table 168. Shaanxi Bosen Biopharmaceutical Ropivacaine Corporation Information
Table 169. Shaanxi Bosen Biopharmaceutical Corporation Information
Table 170. Shaanxi Bosen Biopharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 171. Shaanxi Bosen Biopharmaceutical Main Product
Table 172. Shaanxi Bosen Biopharmaceutical Recent Development
Table 173. Qilu Pharmaceutical Ropivacaine Corporation Information
Table 174. Qilu Pharmaceutical Corporation Information
Table 175. Qilu Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 176. Qilu Pharmaceutical Main Product
Table 177. Qilu Pharmaceutical Recent Development
Table 178. Shenyang Sansheng Pharmaceutical Ropivacaine Corporation Information
Table 179. Shenyang Sansheng Pharmaceutical Corporation Information
Table 180. Shenyang Sansheng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2015-2020)
Table 181. Shenyang Sansheng Pharmaceutical Main Product
Table 182. Shenyang Sansheng Pharmaceutical Recent Development
Table 183. Sales Base and Market Concentration Rate of Raw Material
Table 184. Key Suppliers of Raw Materials
Table 185. Ropivacaine Distributors List
Table 186. Ropivacaine Customers List
Table 187. Market Key Trends
Table 188. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 189. Key Challenges
Table 190. Global Ropivacaine Sales (K Doses) Forecast by Type (2021-2026)
Table 191. Global Ropivacaine Sales Market Share Forecast by Type (2021-2026)
Table 192. Global Ropivacaine Revenue (Million US$) Forecast by Type (2021-2026)
Table 193. Global Ropivacaine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 194. Global Ropivacaine Sales (K Doses) Forecast by Application (2021-2026)
Table 195. Global Ropivacaine Revenue (Million US$) Forecast by Application (2021-2026)
Table 196. Global Ropivacaine Sales (K Doses) Forecast by Region (2021-2026)
Table 197. Global Ropivacaine Sales Market Share Forecast by Region (2021-2026)
Table 198. Global Ropivacaine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 199. Global Ropivacaine Revenue Market Share Forecast by Region (2021-2026)
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Ropivacaine
Figure 2. Global Ropivacaine Sales Market Share by Type: 2020 VS 2026
Figure 3. Lumbar Epidural Administration Product Picture
Figure 4. Thoracic Epidural Administration Product Picture
Figure 5. Regional Block Product Picture
Figure 6. Global Ropivacaine Consumption Market Share by Application: 2020 VS 2026
Figure 7. Anesthesia
Figure 8. Systemic Neuropathic Pain
Figure 9. Postherpes Pain
Figure 10. Post-Operative Pain
Figure 11. Surgical Analgesia
Figure 12. Labor Analgesia
Figure 13. Other
Figure 14. Global Ropivacaine Market Size 2015-2026 (US$ Million)
Figure 15. Global Ropivacaine Sales Capacity (K Doses) (2015-2026)
Figure 16. Global Ropivacaine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Ropivacaine Sales Share by Manufacturers in 2020
Figure 18. Global Ropivacaine Revenue Share by Manufacturers in 2019
Figure 19. The Global 5 and 10 Largest Players: Market Share by Ropivacaine Revenue in 2019
Figure 20. Ropivacaine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Ropivacaine Sales Market Share by Region (2015-2020)
Figure 22. Global Ropivacaine Sales Market Share by Region in 2019
Figure 23. Global Ropivacaine Revenue Market Share by Region (2015-2020)
Figure 24. Global Ropivacaine Revenue Market Share by Region in 2019
Figure 25. North America Ropivacaine Sales Market Share by Country in 2019
Figure 26. North America Ropivacaine Revenue Market Share by Country in 2019
Figure 27. U.S. Ropivacaine Sales Growth Rate (2015-2020) (K Doses)
Figure 28. U.S. Ropivacaine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Canada Ropivacaine Sales Growth Rate (2015-2020) (K Doses)
Figure 30. Canada Ropivacaine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Europe Ropivacaine Sales Market Share by Country in 2019
Figure 32. Europe Ropivacaine Revenue Market Share by Country in 2019
F

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs